Cercar
01/08/2021
Dermatology Life Quality Index in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Brodalumab or Ustekinumab
Lambert, J, Hansen, JB, Sohrt, A, Puig, L. Dermatology Life Quality Index in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Brodalumab or Ustekinumab. Dermatology and Therapy. 2021; 11(4)DOI:10.1007/s13555-021-00545-5. PMID:33988818. IF:3.661(Q2/3D).
01/08/2021
Deterioration of Health-Related Quality of Life After Withdrawal of Risankizumab Treatment in Patients with Moderate-to-Severe Plaque Psoriasis: A Machine Learning Predictive Model
Papp, KA, Soliman, AM, Done, N, Carley, C, Wirtz, EL, Puig, L. Deterioration of Health-Related Quality of Life After Withdrawal of Risankizumab Treatment in Patients with Moderate-to-Severe Plaque Psoriasis: A Machine Learning Predictive Model. Dermatology and Therapy. 2021; 11(4)DOI:10.1007/s13555-021-00550-8. PMID:34019229. IF:3.661(Q2/3D).
01/07/2021
Janus Kinase Inhibitors in Dermatology: Part 2: Applications in Psoriasis, Atopic Dermatitis, and Other Dermatoses
Garcia-Melendo, C, Cubiro, X, Puig, L. Janus Kinase Inhibitors in Dermatology: Part 2: Applications in Psoriasis, Atopic Dermatitis, and Other Dermatoses. Actas Dermo-Sifiliograficas. 2021; 112(7)DOI:10.1016/j.ad.2020.12.006. PMID:34030992. IF:(Q/D).
01/07/2021
From Messengers to Receptors in Psoriasis: The Role of IL-17RA in Disease and Treatment
Vidal, S, Puig, L, Carrascosa-Carrillo, JM, Gonzalez-Cantero, A, Ruiz-Carrascosa, JC, Velasco-Pastor, AM. From Messengers to Receptors in Psoriasis: The Role of IL-17RA in Disease and Treatment. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2021; 22(13)DOI:10.3390/ijms22136740. PMID:34201664. IF:6.208(Q1/3D).
01/07/2021
A case report of PHF6 mosaicism: Beyond the classic Borjeson-Forssman-Lehmann syndrome
Garcia-Melendo, C, Roe, E, Rodriguez-Santiago, B, Amat-Samaranch, V, Cubiro, X, Puig, L, Boronat, S. A case report of PHF6 mosaicism: Beyond the classic Borjeson-Forssman-Lehmann syndrome. PEDIATRIC DERMATOLOGY. 2021; 38(4)DOI:10.1111/pde.14636. PMID:34041787. IF:1.997(Q3/7D).
01/10/2022
Retiform purpura in an 80-year-old woman
Carmona-Rocha, E, Iznardo, H, Puig, L. Retiform purpura in an 80-year-old woman. INTERNATIONAL JOURNAL OF DERMATOLOGY. 2022; 61(10)DOI:10.1111/ijd.16120. PMID:35106756. IF:3.600(Q1/3D).
01/07/2022
Prevalence of most common skin diseases in Europe: a population-based study
Richard, MA, Paul, C, Nijsten, T, Gisondi, P, Salavastru, C, Taieb, C, Trakatelli, M, Puig, L, Stratigos, A, EADV Burden Skin Dis Project Team. Prevalence of most common skin diseases in Europe: a population-based study. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2022; 36(7)DOI:10.1111/jdv.18050. PMID:35274366. IF:9.200(Q1/1D).
19/05/2022
Impact of PASI response on work productivity and the effect of risankizumab on indirect costs using machine learning in patients with moderate-to-severe psoriasis
Lebwohl, M, Soliman, AM, Yang, HB, Wang, J, Freimark, J, Puig, L. Impact of PASI response on work productivity and the effect of risankizumab on indirect costs using machine learning in patients with moderate-to-severe psoriasis. JOURNAL OF DERMATOLOGICAL TREATMENT. 2022; 33(4)DOI:10.1080/09546634.2021.1919287. PMID:33899655. IF:2.900(Q2/4D).